To date, the TLR9 SNPs have been showing to modulate the risk of CMV infection in individuals with the allogeneic hematopoietic stem cell transplantation (allo-HSCT) [11,12], renal transplant recipients [13,14], and infants [10,15]. The gene discussed is TLR9; the disease is cytomegalovirus infection.